Anna B. Meier
Impact in
-
- Liver Diseases and Immunity
-
- Liver Disease Diagnosis and Treatment
Papers in
-
- CRISPR and Genetic Engineering 3
- Pluripotent Stem Cells Research 1
- Insect Resistance and Genetics 1
- Protein Tyrosine Phosphatases 1
-
- Neuroscience and Neural Engineering 4
- Co-authors
- Andreas Geier (1 shared paper)Miroslaw Kornek (1 shared paper)Thomas Tschernig (1 shared paper)Henrike Julich‐Haertel (1 shared paper)Sonja Djudjaj (1 shared paper)Frank Lammert (1 shared paper)Peter Boor (1 shared paper)Alessandra Moretti (5 shared papers)
- Journals
- Stem Cell Research (3 papers)Frontiers in Bioscience-Landmark (1 paper)Journal of Hepatology (1 paper)iScience (1 paper)Nature Biotechnology (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Anna B. Meier
10 papers receiving 224 citations
Peers
Comparison fields: 5 of 57
- Hepatology 24
- Epidemiology 58
- Immunology 37
- Molecular Biology 98
- Cardiology and Cardiovascular Medicine 25
Countries citing papers authored by Anna B. Meier
This map shows the geographic impact of Anna B. Meier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna B. Meier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna B. Meier more than expected).
Fields of papers citing papers by Anna B. Meier
This network shows the impact of papers produced by Anna B. Meier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna B. Meier. The network helps show where Anna B. Meier may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna B. Meier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 79 | |
| 2 | 2023 | 54 | |
| 3 | 2018 | 37 | |
| 4 | 2009 | 22 | |
| 5 | 2022 | 12 | |
| 6 | 2021 | 11 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 2 | |
| 10 | [Prazosin in the combined treatment of moderate to severe hypertension]. | 1979 | 1 |
| 11 | 2016 | 0 |
About Anna B. Meier
Anna B. Meier is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Cardiology and Cardiovascular Medicine, Radiation and Management of Technology and Innovation, having authored 11 papers that have together received 225 indexed citations. Recurring topics across this work include Neuroscience and Neural Engineering (4 papers), CRISPR and Genetic Engineering (3 papers), Intellectual Property and Patents (1 paper), Galectins and Cancer Biology (1 paper), Pluripotent Stem Cells Research (1 paper), Insect Resistance and Genetics (1 paper), Protein Tyrosine Phosphatases (1 paper) and Biomedical Ethics and Regulation (1 paper). The work is most often cited by research in Hepatology (24 citations), Epidemiology (58 citations), Immunology (37 citations), Molecular Biology (98 citations) and Cardiology and Cardiovascular Medicine (25 citations). Anna B. Meier has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Andreas Geier, Miroslaw Kornek, Thomas Tschernig, Henrike Julich‐Haertel, Sonja Djudjaj, Frank Lammert, Peter Boor, Alessandra Moretti, Fangfang Zhang and Karl‐Ludwig Laugwitz. Their work appears in journals such as Stem Cell Research, Frontiers in Bioscience-Landmark, Journal of Hepatology, iScience and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.